| [1] | 王丽娟,杨旭燕,汪慧英.结缔组织病肺间质病变的诊治进展[J].细胞与分子免疫学杂志,2011,27(1):115. |
| [2] | ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.ATS statement:guidelines for the six-minute walk test[J].Am J Respir Crit Care Med,2002,166 (1):111. |
| [3] | WARRICK JH,BHALLA M,SCHABEL SI,et al.High resolution computed tomography in early scleroderma lung disease[J].J Rheumatol,1991,18(10):1520. |
| [4] | 邱建国,潘解萍,聂建新,等.MSCT 肺密度测定评价弥漫性结缔组织病的初步探讨[J].上海医学影像,2003,12(1):20. |
| [5] | 李杨,桂明,李英,等.结缔组织病肺间质病变的临床特点及治疗效果分析[J].临床肺科杂志,2011,16(5):714. |
| [6] | CHUNG HH,DAI ZK,WU BN,et al.The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase[J].Br J Pharmacol,2010,160(4):971. |
| [7] | 刘爱军,王栋,朱耀武,等.法舒地尔对人肺动脉平滑肌细胞的抑制作用研究[J].中华实用诊断与治疗杂志,2011,25(1):11. |
| [8] | MASAYUKI S,MASANORI N,GOTO TM,et al.Rho-kinase phosphorylatese NOS at threonine 495 in endothelial cells[J].Biophys Biochem Res Commun,2007,361(3):462. |
| [9] | HIROKI J,SHIMOKAWA H,MUKAI Y,et al.Adivergent effects of estrogen and nicotine on Rho kinase expression in human coronary vascular smooth muscle cells[J].Biophys Biochem Res Commun,2005,326(2):154. |
| [10] | YASUDA T,TADA Y,TANABE N,et al.Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type Ⅱ bone morphogenetic protein receptor gene[J].Am J Physiol Lung Cell MolPhysiol,2011,30(5):667. |